Source link : https://newshealth.biz/health-news/tirzepatides-cv-benefit-prevent-age-calculator-rectal-injection-for-bp-reduction/
(MedPage Today) — The GIP/GLP-1 dual agonist tirzepatide (Mounjaro) showed cardiovascular protective benefits over dulaglutide (Trulicity) in the phase III SURPASS-CVOT trial of diabetes patients with heart disease, Lilly announced. The FDA approved… Source link : https://www.medpagetoday.com/cardiology/generalcardiology/116835 Author : Publish date : 2025-08-05 17:02:00 Copyright for syndicated content belongs to the linked Source.
The post Tirzepatide’s CV Benefit; PREVENT Age Calculator; Rectal Injection for BP Reduction? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-05 17:02:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8